Drugs / MK0822A
last change Jul 2006 re-read 3 minutes ago

MK0822A

Developed for
vitamin D deficiency
Investigated by
Merck Sharp & Dohme LLC

Trials 1

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00242476 Sep 2005 → Jul 2006 vitamin D deficiency Merck Sharp & Dohme LLC Completed Missed primary

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as MK0822A ClinicalTrials.gov intervention name — accepted as the source's own label NCT00242476 ↗